CRTC2
Basic information
Region (hg38): 1:153947669-153958615
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CRTC2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 47 | 47 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 47 | 0 | 0 |
Variants in CRTC2
This is a list of pathogenic ClinVar variants found in the CRTC2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-153948119-C-T | not specified | Uncertain significance (Feb 17, 2023) | ||
1-153948129-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
1-153948164-G-C | not specified | Uncertain significance (Dec 16, 2023) | ||
1-153948215-C-T | not specified | Uncertain significance (Jul 09, 2024) | ||
1-153948220-C-G | not specified | Uncertain significance (Jun 09, 2022) | ||
1-153948266-T-C | not specified | Uncertain significance (May 09, 2022) | ||
1-153948282-C-T | not specified | Uncertain significance (Oct 06, 2021) | ||
1-153948308-G-A | not specified | Uncertain significance (Nov 12, 2021) | ||
1-153948481-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
1-153948493-G-C | not specified | Uncertain significance (May 21, 2024) | ||
1-153948526-T-C | not specified | Uncertain significance (Aug 07, 2024) | ||
1-153948609-G-C | not specified | Uncertain significance (Jan 10, 2023) | ||
1-153949138-T-C | not specified | Uncertain significance (Dec 28, 2023) | ||
1-153949163-A-C | not specified | Uncertain significance (Aug 12, 2021) | ||
1-153949180-G-A | not specified | Uncertain significance (Mar 07, 2023) | ||
1-153949209-C-G | not specified | Uncertain significance (Oct 09, 2024) | ||
1-153949294-G-A | not specified | Uncertain significance (Nov 25, 2024) | ||
1-153949315-T-C | not specified | Uncertain significance (Sep 12, 2024) | ||
1-153949335-G-A | not specified | Uncertain significance (May 04, 2023) | ||
1-153949381-C-T | not specified | Uncertain significance (Jun 24, 2022) | ||
1-153951289-T-C | not specified | Uncertain significance (Dec 13, 2023) | ||
1-153951364-G-T | not specified | Uncertain significance (Nov 29, 2023) | ||
1-153951378-C-T | not specified | Uncertain significance (Sep 27, 2021) | ||
1-153951415-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
1-153951441-G-A | not specified | Uncertain significance (Oct 16, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CRTC2 | protein_coding | protein_coding | ENST00000368633 | 14 | 10957 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.999 | 0.00110 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.769 | 356 | 399 | 0.892 | 0.0000215 | 4412 |
Missense in Polyphen | 143 | 179.59 | 0.79626 | 2033 | ||
Synonymous | -0.362 | 171 | 165 | 1.04 | 0.00000827 | 1538 |
Loss of Function | 4.84 | 3 | 33.0 | 0.0909 | 0.00000205 | 316 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000562 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000265 | 0.0000264 |
Middle Eastern | 0.0000562 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates gluconeogenesis as a component of the LKB1/AMPK/TORC2 signaling pathway. Regulates the expression of specific genes such as the steroidogenic gene, StAR. Potent coactivator of PPARGC1A and inducer of mitochondrial biogenesis in muscle cells. Also coactivator for TAX activation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeats (LTR). {ECO:0000269|PubMed:14506290, ECO:0000269|PubMed:14536081, ECO:0000269|PubMed:15454081, ECO:0000269|PubMed:16809310, ECO:0000269|PubMed:16817901, ECO:0000269|PubMed:16980408, ECO:0000269|PubMed:17210223}.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);Insulin resistance - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Metformin Pathway, Pharmacodynamic;AMP-activated Protein Kinase (AMPK) Signaling;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;LKB1 signaling events
(Consensus)
Recessive Scores
- pRec
- 0.237
Intolerance Scores
- loftool
- 0.235
- rvis_EVS
- -0.69
- rvis_percentile_EVS
- 15.12
Haploinsufficiency Scores
- pHI
- 0.257
- hipred
- Y
- hipred_score
- 0.658
- ghis
- 0.595
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.675
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Crtc2
- Phenotype
- liver/biliary system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- gluconeogenesis;viral process;positive regulation of CREB transcription factor activity;glucose homeostasis;histone H3-K9 acetylation;positive regulation of transcription by RNA polymerase II;protein homotetramerization;toxin transport
- Cellular component
- nucleus;nucleoplasm;cytoplasm;extracellular exosome
- Molecular function
- chromatin binding;protein binding;cAMP response element binding protein binding